Table 1.
Patient characteristics n (%)
| Characteristic | No. of patients (n = 64) |
| Gender | |
| Male | 38 (59) |
| Female | 26 (41) |
| Age (yr) | |
| Median, 49 | |
| Range, 24-75 | |
| Lugano staging system | |
| I | 53 (83) |
| II1 | 11 (17) |
| Disease location | |
| Cardia | 2 (3) |
| Fundus | 5 (8) |
| Body | 35 (55) |
| Antrum | 7 (11) |
| Diffuse | 15 (23) |
| H. pylori infection | |
| Negative | 33 (52) |
| Positive | 31 (48) |
| Prior treatment | |
| H. pylori eradication | 25 (39) |
| Chemotherapy | 9 (14) |
| Combined | 6 (9) |
| None | 24 (38) |
| Response to prior treatment | |
| Complete histologic remission (CR) | 17 |
| Responding residual disease (rRD) | 11 |
| No change (NC) | 12 |
| Not evaluable | 24 |
| Radiation dose | Median, 36 Gy |
| ≥ 40 Gy | 18 (28) |
| 36 Gy | 38 (59) |
| 30 Gy | 8 (13) |
| RT technique | |
| AP/PA | 25 (39) |
| 3-D conformal | 39 (61) |
H. pylori: Helicobacter pylori; RT: Radiation therapy; AP/PA: Anteroposterior/posteroanterior.